Evidence map›Paper›PMID 28515491›Full record

ReviewNature reviews. Neuroscience2017

The emerging field of epigenetics in neurodegeneration and neuroprotection.

Jee-Yeon Hwang, Kelly A Aromolaran, R Suzanne Zukin

Erratum issuedAbstract readReview
In one paragraph

Review in Nature reviews. Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 182 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
182citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

182 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Comprehensive characterization of the RNA editing landscape in the human aging brains with Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  20. Review

122 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Jee-Yeon HwangDominick P. Purpura Department of Neuroscience, Rose F. Kennedy Center, Room 610, Albert Einstein College of Medicine, 1300 Morris Park Avenue, New York, New York 10461, USA.
Kelly A AromolaranDominick P. Purpura Department of Neuroscience, Rose F. Kennedy Center, Room 610, Albert Einstein College of Medicine, 1300 Morris Park Avenue, New York, New York 10461, USA.
R Suzanne ZukinDominick P. Purpura Department of Neuroscience, Rose F. Kennedy Center, Room 610, Albert Einstein College of Medicine, 1300 Morris Park Avenue, New York, New York 10461, USA.

Funding

REST-Activated Program of Gene Expression in IschemiaR01NS046742 · NINDS · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI ZUKIN, R. SUZANNE · 2004 to 2019
$6.1M
Dysregulation of mTOR Signaling in Fragile X SyndromeR01MH092877 · NIMH · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ZUKIN, R. SUZANNE · 2011 to 2021
$4.3M
Epigenetic Remodeling of NMDA ReceptorsR01HD083828 · NICHD · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ZUKIN, R. SUZANNE · 2016 to 2020
$1.7M
NICHD NIH HHS R01 HD083828NIMH NIH HHS R01 MH092877NINDS NIH HHS R01 NS046742
6 · The paper itself

Abstract

Epigenetic mechanisms - including DNA methylation, histone post-translational modifications and changes in nucleosome positioning - regulate gene expression, cellular differentiation and development in almost all tissues, including the brain. In adulthood, changes in the epigenome are crucial for higher cognitive functions such as learning and memory. Striking new evidence implicates the dysregulation of epigenetic mechanisms in neurodegenerative disorders and diseases. Although these disorders differ in their underlying causes and pathophysiologies, many involve the dysregulation of restrictive element 1-silencing transcription factor (REST), which acts via epigenetic mechanisms to regulate gene expression. Although not somatically heritable, epigenetic modifications in neurons are dynamic and reversible, which makes them good targets for therapeutic intervention.

Indexed as

NeuroprotectionAnimalsDNA MethylationEpigenesis, GeneticEpigenomicsHumansNeurodegenerative Diseases

Identifiers

PMID28515491
PMCPMC6380351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.